Walgreens Boots Alliance Announces Key Leadership Appointments Live

DEERFIELD, Ill., April 25, 2019 – Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced today a number of key leadership appointments to accelerate its transformation, lead strategies for long-term sustainable growth and drive operational excellence.

The new appointments are Global Chief Digital Officer Gunjan Bhow, Global Controller and Chief Accounting Officer Heather Dixon, Global Chief Marketing Officer Vineet Mehra, Global Chief Commercial Officer Annie Murphy and Global Chief Supply Chain Officer Colin Nelson. These leaders all started their roles in recent months. The global chief digital officer, global chief marketing officer, global chief commercial officer and global chief supply chain officer are newly created roles at WBA.

The following are brief biographies for the new appointees. Full biographies and photographs are available on request.

• Gunjan Bhow, Global Chief Digital Officer

Gunjan will lead WBA’s global efforts to identify customer needs and to develop innovative solutions that can delight and improve the lives of tens of millions of customers across the world. He brings over 25 years of experience leading customer-centric digital transformation and developing category-defining products that have been adopted by over a hundred million consumers worldwide and generated billions of dollars in revenue. Gunjan also brings a deep and rich skillset of defining, developing and operating digital products and businesses honed at leading companies including the Walt Disney Company, where he was senior vice president and general manager. At Disney, he led transformative initiatives across direct-to-consumer, subscription, commerce, data and loyalty. Prior to Disney, Gunjan led digital businesses at Amazon, Microsoft and Plantronics.
 

• Heather Dixon, Global Controller and Chief Accounting Officer

Heather will oversee WBA’s global controllership organization with a focus on financial accounting and reporting as well as supporting systems and controls. She brings to the company extensive experience in U.S. and global finance and in the health care and consumer goods sectors, and has a proven track record leading diverse teams in large, complex organizations. She joins from Aetna Inc., where she was vice president, controller and chief accounting officer from 2017, and, prior to that, assistant controller. Before that, she served as vice president and assistant controller at PepsiCo Inc. She was a vice president at American Express from 2005 to 2015 in roles of increasing responsibility, with a focus on technical accounting, financial reporting and project delivery. Dixon began her career at PricewaterhouseCoopers from 1995 to 2005, where she was a member of the audit practice in the U.S. and the global capital markets group in the UK.
 

• Vineet Mehra, Global Chief Marketing Officer

Vineet will lead and direct all marketing activities across the global enterprise. He is a truly global marketer and business leader having lived in and led diverse teams across three continents. Vineet’s background combines global experiences in core consumer packaged good categories such as health, beauty and personal care along with pure-play digital and e-commerce technology business models. In 2018, Forbes listed him as one of their Top 50 CMOs defining the future of marketing and in early 2019, Ad Age announced him as one of their Top 20 Tech Savvy CMOs. Prior to WBA, he was global CMO at Ancestry.com, the world’s largest consumer genomics and genealogy company, leading their worldwide direct to consumer marketing programs and subscription revenue model efforts. Before that, he was global president for Johnson & Johnson’s baby care division and was also global president of marketing services. He has also held top marketing positions at Avon, Novartis Consumer Health and Procter & Gamble.
 

• Annie Murphy, Global Chief Commercial Officer

Annie will lead Global Brands, the company’s portfolio of highly regarded product brands, as well as all commercial and third-party relationships. Annie is a highly accomplished commercial leader with a career that combines experiences across global retail and consumer brands businesses. Her prior role was senior vice president and chief customer officer at WBA. Annie has been with WBA for eight years and was previously the commercial director of Boots UK & Ireland. Before joining WBA she was managing director of the Birds Eye foods business and has also held a number of senior commercial leadership roles in P&G, PepsiCo and Tesco.
 

• Colin Nelson, Chief Global Supply Chain Officer

Colin will lead WBA’s global supply chain, improve efficiencies and build on the current network to enhance customer satisfaction as the company continues to build its digital presence. He has extensive experience in leadership of operations and end-to-end supply chains to deliver significant business improvement. He previously led industrial operations at Bunge, a global agri-food company headquartered in the U.S. Prior to that, he served as senior vice president, global supply chain, consumer health division at GlaxoSmithKline. He has also held top global supply chain positions at Firmenich and Unilever. Colin’s experience is truly global as he has worked and lived in Africa, Asia, Europe and North and South America.

ENDS

Notes to Editors:

About Walgreens Boots Alliance

Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led, health and wellbeing enterprise. The company's heritage of trusted health care services through community pharmacy care and pharmaceutical wholesaling dates back more than 100 years.

Walgreens Boots Alliance is the largest retail pharmacy, health and daily living destination across the U.S. and Europe. Walgreens Boots Alliance and the companies in which it has equity method investments together have a presence in more than 25 countries and employ more than 415,000 people. The company is a global leader in pharmacy-led, health and wellbeing retail and, together with its equity method investments, has more than 18,500 stores in 11 countries as well as one of the largest global pharmaceutical wholesale and distribution networks, with more than 390 distribution centers delivering to more than 230,000 pharmacies, doctors, health centers and hospitals each year in more than 20 countries. In addition, Walgreens Boots Alliance is one of the world’s largest purchasers of prescription drugs and many other health and wellbeing products.

The company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as increasingly global health and beauty product brands, such as No7, Soap & Glory, Liz Earle, Sleek MakeUP and Botanics.

Walgreens Boots Alliance is proud to be a force for good, leveraging many decades of experience and its international scale, to care for people and the planet through numerous social responsibility and sustainability initiatives that have an impact on the health and wellbeing of millions of people.

Walgreens Boots Alliance is included in Fortune magazine’s 2019 list of the World’s Most Admired Companies and ranked first in the food and drugstore category. This is the 26th consecutive year that Walgreens Boots Alliance or its predecessor company, Walgreen Co., has been named to the list.

More company information is available at www.walgreensbootsalliance.com.

(WBA-GEN)

Cautionary Note Regarding Forward-Looking Statements: All statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance or outcomes and involve risks, assumptions and uncertainties, including those described in Item 1A (Risk Factors) of our Form 10-K for the fiscal year ended August 31, 2018 and Form 10-Q for the quarter ended February 28, 2019 and in other documents that we file or furnish with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially. These forward-looking statements speak only as of the date they are made. Except to the extent required by law, we do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.